Bgne us stock
BGNE | BeiGene Ltd. ADR Overview | MarketWatch BeiGene Ltd. ADR. BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs BGNE - Stock quote for BEIGENE, LTD. - MSN Money View the latest BGNE stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of BEIGENE, LTD.. BGNE Stock Quote - BeiGene, Ltd. American Depositary ... Mar 30, 2020 · Stock quote for BeiGene, Ltd. American Depositary Shares Common Stock (BGNE) with real-time last sale and extended hours stock prices, company news, … BGNE Stock Price, Forecast & News (Beigene) | MarketBeat
Market Cap, 10.362 Billion, Shares Outstanding, 61.07 Million, Avg Volume, 449.914 Thousand. 1-Yr BETA vs S&P TR, 0.756, Current Ratio, 7.89, Quick Ratio
In depth view into BGNE (BeiGene) stock including the latest price, news, dividend history, earnings information and financials. 12 Nov 2019 12, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; of U.S. dollars, except for shares, American Depositary Shares (ADSs), Market Cap, 10.362 Billion, Shares Outstanding, 61.07 Million, Avg Volume, 449.914 Thousand. 1-Yr BETA vs S&P TR, 0.756, Current Ratio, 7.89, Quick Ratio 13 Nov 2019 BeiGene, Ltd. (NASDAQ:BGNE): BGNE leads the way today as the best American Depositary Shares (Each representing four equity shares) 4 Nov 2019 Shares of BeiGene Ltd (SEHK: 6160) (NASDAQ: BGNE), a biopharmaceutical company with a presence in the US and China, jumped last
Stock analysis for BeiGene Ltd (BGNE:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Beigene Ltd (BGNE:NSQ) company profile with history, revenue, mergers & acquisitions, peer analysis, Currency figures normalised to Beigene Ltd's reporting currency: US Dollar USD 47.16%Per cent of shares held by top holders
BGNE - Benzinga
BGNE - Benzinga
View BGNE's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Analyzing Beigene (NASDAQ:BGNE) stock? View BGNE's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. the United States, and internationally. Its commercial
BGNE stock quote, chart and news. Get BeiGene Ltd.'s stock price today. BeiGene reports Abraxane shortage in China (NASDAQ:BGNE ... Mar 25, 2020 · BeiGene (NASDAQ:BGNE) announces a supply disruption in Abraxane (nanoparticle albumin-bound paclitaxel) due to the suspension of importation instituted by the China National Medical Products NASDAQ:BGNE BeiGene Ltd. Sponsored ADR Stock Analysis ... Summary quote, performance, and fundamental analysis for NASDAQ:BGNE BeiGene Ltd. Sponsored ADR
BeiGene, Ltd. American Depositary Shares (BGNE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are Real time BeiGene (BGNE) stock price quote, stock graph, news & analysis. EDT View Interactive BGNE Charts. BeiGene, Ltd. American Depositary Shares BGNE: Get the latest BeiGene stock price and detailed information including BGNE news, historical charts and realtime prices. Shares Outstanding 77.3M. Beta 1.19. Dividend (Yield) - Abraxane shortage in China · Week In Review: Nanjing Legend Files To Stage IPO In The U.S.. more